Cargando…

Radiation therapy for oligometastatic oropharyngeal cancer

At presentation, isolated metastasis from oropharyngeal squamous cell carcinoma is rare. Liver is a relatively uncommon first site of failure, especially in the absence of other distant metastases, particularly without diagnosis of lung metastases. We report on a case of HPV-related oropharyngeal sq...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martini, Stefania, Arcadipane, Francesca, Franco, Pierfrancesco, Iorio, Giuseppe C., Bartoncini, Sara, Gallio, Elena, Guarneri, Alessia S., Ricardi, Umberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Institute of Radiology. 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068095/ https://www.ncbi.nlm.nih.gov/pubmed/32201599 http://dx.doi.org/10.1259/bjrcr.20190021

Ejemplares similares

Ocular Complications After Radiation Therapy: An Observational Study
por: Nuzzi, Raffaele, et al.
Publicado: (2020)

The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer
por: Franco, Pierfrancesco, et al.
Publicado: (2018)

Clinical applications of stereotactic radiation therapy for oligometastatic cancer patients: a disease-oriented approach
por: Ricardi, Umberto, et al.
Publicado: (2016)

Incorporating (18)FDG-PET-defined pelvic active bone marrow in the automatic treatment planning process of anal cancer patients undergoing chemo-radiation
por: Franco, Pierfrancesco, et al.
Publicado: (2017)

Bone Marrow-Sparing IMRT in Anal Cancer Patients Undergoing Concurrent Chemo-Radiation: Results of the First Phase of a Prospective Phase II Trial
por: Arcadipane, Francesca, et al.
Publicado: (2020)

Variability of clinical target volume delineation for rectal cancer patients planned for neoadjuvant radiotherapy with the aid of the platform Anatom-e
por: Franco, Pierfrancesco, et al.
Publicado: (2018)

The importance of IL-6 blockade beyond the COVID-19 pandemic: Consideration for cancer care()
por: Iorio, Giuseppe Carlo, et al.
Publicado: (2020)

An external validation of the Candiolo nomogram in a cohort of prostate cancer patients treated by external‐beam radiotherapy
por: Gabriele, Domenico, et al.
Publicado: (2021)

To resect or not to resect?—the dilemma in oligometastatic breast cancer
por: Lonardi, Sara, et al.
Publicado: (2022)

Role of Radiosurgery and Stereotactic Ablative Radiotherapy for Oligometastatic Non-Oncogene Addicted NSCLC
por: Badellino, Serena, et al.
Publicado: (2022)

Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational study
por: Franco, Pierfrancesco, et al.
Publicado: (2018)

Radiation-Induced Lymphopenia Beyond the COVID-19 Pandemic
por: Iorio, Giuseppe Carlo, et al.
Publicado: (2020)

Stereotactic ablative radiotherapy for oligometastatic prostate cancer
por: Gallizia, Elena, et al.
Publicado: (2022)

Concurrent Chemoradiation in Anal Cancer Patients Delivered with Bone Marrow-Sparing IMRT: Final Results of a Prospective Phase II Trial
por: Arcadipane, Francesca, et al.
Publicado: (2021)

Liver magnetic resonance imaging for evaluation of response to treatment after stereotactic body radiation therapy of hepatocellular carcinoma
por: Serafini, Alessandro, et al.
Publicado: (2022)

The changing role of radiation therapy in the management of oligometastatic disease
por: Tharmalingham, H., et al.
Publicado: (2017)

Radiation therapy for oligometastatic bone disease in breast cancer
por: Katayama, Norihisa, et al.
Publicado: (2020)

Predictors of Bone Metastases at (68)Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer (HSPC) Patients with Early Biochemical Recurrence or Persistence
por: Rovera, Guido, et al.
Publicado: (2022)

Stereotactic radiation therapy for oligometastatic esophagogastric adenocarcinoma: outcome and prognostic factors
por: Franceschini, Davide, et al.
Publicado: (2023)

Radiation therapy for older patients with brain tumors
por: Minniti, Giuseppe, et al.
Publicado: (2017)

Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer
por: Ahmed, Kamran A., et al.
Publicado: (2013)

Efficacy of low-dose radiotherapy (2 Gy × 2) in the treatment of marginal zone and mucosa-associated lymphoid tissue lymphomas
por: Cerrato, Marzia, et al.
Publicado: (2021)

Squamous cell carcinoma of the prostate: long-term survival after combined chemo-radiation
por: Munoz, Fernando, et al.
Publicado: (2007)

Sinonasal Side Effects of Chemotherapy and/or Radiation Therapy for Head and Neck Cancer: A Literature Review
por: Riva, Giuseppe, et al.
Publicado: (2022)

Knowing When to Use Stereotactic Ablative Radiation Therapy in Oligometastatic Cancer
por: Franceschini, Davide, et al.
Publicado: (2021)

Event-free survival after (68) Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapy
por: Ceci, Francesco, et al.
Publicado: (2022)

Volumetric burden of metastatic lesions drives outcomes in patients with extracranial oligometastatic disease
por: Cao, Yilin, et al.
Publicado: (2021)

Surgical treatment in oligometastatic breast cancer
por: Vargas, Catalina, et al.
Publicado: (2019)

Limited Stage Follicular Lymphoma: Current Role of Radiation Therapy
por: Filippi, Andrea Riccardo, et al.
Publicado: (2016)

Metastasectomy or Stereotactic Body Radiation Therapy With or Without Systemic Therapy for Oligometastatic Esophagogastric Cancer
por: Kroese, Tiuri E., et al.
Publicado: (2022)

Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier)
por: Casadei-Gardini, Andrea, et al.
Publicado: (2019)

Linear accelerator-based stereotactic body radiation therapy in the treatment of oligometastatic disease
por: Yamashita, Hideomi, et al.
Publicado: (2020)

Stereotactic body radiation therapy for oligometastatic pulmonary tumors from cervical cancer
por: Hou, Xiaorong, et al.
Publicado: (2019)

Radiation Therapy in the Definitive Management of Oligometastatic Prostate Cancer: The Johns Hopkins Experience
por: Deek, Matthew P., et al.
Publicado: (2019)

Multidisciplinary Therapy in Men with Newly Diagnosed Oligometastatic Prostate Cancer
por: Watanabe, Kazuhiro, et al.
Publicado: (2021)

A critical review on oligometastatic disease: a radiation oncologist’s perspective
por: Pacifico, Pietro, et al.
Publicado: (2022)

Peripheral blood complete remission after splenic irradiation in Mantle-Cell Lymphoma with 11q22-23 deletion and ATM inactivation
por: Filippi, Andrea Riccardo, et al.
Publicado: (2006)

The Evolving Role of Radiotherapy in Early Stage Hodgkin’s Lymphoma
por: Ricardi, Umberto, et al.
Publicado: (2014)

The efficacy of Stereotactic body radiation therapy and the impact of systemic treatments in oligometastatic patients from prostate cancer
por: Franzese, Ciro, et al.
Publicado: (2018)

Results of Radiation Therapy as Local Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer
por: Billing, David L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v7vk1568dkb31frgc17r93kmrr